Form DRS - Draft Registration Statement:
SEC Accession No. 0000950123-14-003311
Filing Date
2014-03-25
Accepted
2014-03-25 17:08:54
Documents
14

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 3321544
2 GRAPHIC g690627g93c27.jpg GRAPHIC 5743
3 GRAPHIC g690627g04s34.jpg GRAPHIC 4476
4 GRAPHIC g690627g09a67.jpg GRAPHIC 5864
5 GRAPHIC g690627g10l29.jpg GRAPHIC 8223
6 GRAPHIC g690627g10t49.jpg GRAPHIC 7000
7 GRAPHIC g690627g23p68.jpg GRAPHIC 4605
8 GRAPHIC g690627g26q68.jpg GRAPHIC 6869
9 GRAPHIC g690627g36i66.jpg GRAPHIC 3023
10 GRAPHIC g690627g46w07.jpg GRAPHIC 6165
11 GRAPHIC g690627g48j87.jpg GRAPHIC 16470
12 GRAPHIC g690627g66t27.jpg GRAPHIC 5223
13 GRAPHIC g690627g67x04.jpg GRAPHIC 6164
14 filename14.htm COVER 7695
  Complete submission text file 0000950123-14-003311.txt   3442168
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus MI Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

EIN.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-00531 | Film No.: 14716684
SIC: 2835 In Vitro & In Vivo Diagnostic Substances